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Abstract
Disulfide-rich peptide toxins found in the secretions of venomous organisms such as snakes, spiders, scorpions, leeches, and
marine snails are highly efficient and effective tools for novel therapeutic drug development. Venom peptide toxins have
been used extensively to characterize ion channels in the nervous system and platelet aggregation in haemostatic systems.
A significant hurdle in characterizing disulfide-rich peptide toxins from venomous animals is obtaining significant quantities
needed for sequence and structural analyses. Presented here is a strategy for the structural characterization of venom
peptide toxins from sample limited (4 ng) specimens via direct mass spectrometry sequencing, chemical synthesis and NMR
structure elucidation. Using this integrated approach, venom peptide Tv1 from Terebra variegata was discovered. Tv1
displays a unique fold not witnessed in prior snail neuropeptides. The novel structural features found for Tv1 suggest that
the terebrid pool of peptide toxins may target different neuronal agents with varying specificities compared to previously
characterized snail neuropeptides.
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There is a need to discover new compounds that enhance the
drug pipeline for treating ailments. The disulfide-rich peptide
toxins found in venomous organisms such as snakes, spiders,
scorpions, leeches, and marine snails are highly efficient and
effective for manipulating physiological pathways and for novel
therapeutic and insecticide drug development [1–4]. In an effort to
identify novel disulfide compounds from venomous snails, we have
investigated the Terebridae, a sister group to the more familiar
cone snails. Novel peptide toxins from the Terebridae would
enhance the pool of therapeutic compounds available for
biomedical research. Venomous disulfide-rich compounds include
ion channel and enzyme inhibitors, growth factors, and structural
or ligand-binding domains [5]. The disulfide-rich peptide library
produced by venomous organisms is estimated to contain well over
2 million compounds. The potential and promise of these
compounds are evidenced by breakthroughs such as, angioten-
sin-converting enzyme (ACE)-inhibitor, Captopril [6] and more
recently, ziconotide (Prialt), the first drug from a venomous marine
snail, Conus magus, which is used to treat chronic pain in HIV and
cancer patients [7]. Peptides, while currently not as bio-available
as small molecule therapeutics, have advantages of higher target
specificity and selectivity, and decreased toxicity. Despite their
advantages, the use of peptides in drug development lags in the
discovery and characterization stages. Obtaining workable quan-
tities of venomous natural products has remained a significant
challenge due to the large amount of material that has traditionally
been needed to identify and structurally characterize peptidic
compounds [8–12]. A sensitive and robust method for discovery
and characterization of disulfide-rich peptides from sample limited
venom sources would facilitate their application as biochemical
tools and potential drug development targets [13–15]. Presented
here is an integrated approach of liquid chromatography mass
spectrometric sequencing, chemical peptide synthesis, and NMR
for the rapid identification and characterization of sample limited
bioactive disulfide-rich venomous snail peptide toxins (Fig. 1).
Structural characterization of Terebra variegata peptide toxin Tv1
was accomplished using a total venom sample of 4 ng, an amount
that would previously make characterization of venom compo-
nents almost impossible [16,17].
Tv1 is the first peptide structurally characterized from a terebrid
snail. Terebrids are part of the Conoidean superfamily of
predatory mollusks, which includes cone snails and turrids
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[18,19]. Tv1 is a novel twenty-one amino acid teretoxin peptide
with a cysteine scaffold similar to the M-superfamily of cone
snail neurotoxins, CC-C-C-CC. Apart from the cysteine
pattern, there is no sequence homology between Tv1, TR(I/
L)CCGCYWNGSKDVCSQSCC, and known M superfamily
conotoxins from Conus snails (Table 1). Conoidean venoms are a
rich source of neuroactive disulfide-rich peptides, used to
investigate cellular communication in the nervous system [17–
22] and have diverse biomedical applications, including pain
therapy [23,24]. In contrast to conotoxins, terebrid toxins,
teretoxins, which were recently identified, [25,26] are an untapped
resource for discovering novel neuropeptides. The sequence and
structural characterization approach presented here significantly
reduces the number of snails needed, while allowing for rapid
characterization of venom components, in an effort to conserve
natural resources (Fig. 1).
Results and Discussion
Venom Extraction and De-Novo Sequencing of Tv1
The primary sequence characterization of Tv1 was accom-
plished using charge-enhanced Electron Transfer Dissociation
(ETD) in combination with traditional Collisional Activated
Dissociation (CAD) on reduced and alkylated Terebra variegata
venom [27]. The peptide toxins in the crude venom were reduced
and subsequently alkylated using either iodoacetamide or N, N-
dimethyl-2-chloro-ethylamine [27]. The latter converts every
cysteine residue into a dimethyl lysine analogue, which increases
the charge state of each cysteine-rich peptide toxin, resulting in
excellent sequence coverage with ETD.
Combining complementary dissociation strategies CAD and
ETD facilitates de novo sequencing, as each dissociation strategy has
specific fragmentation characteristics, which can be used to
confirm the corresponding ETD and CAD spectra (Fig. 1). This
is advantageous as peptide toxin sequences can be obtained
directly from crude venom without prior fractionation and using
only mass spectrometry [27]. This feature is particularly important
for sequencing peptide toxins from animals producing minimal
amounts of venom, such as terebrids, where only nanogram
quantities are extracted from each snail specimen. Four nano-
grams of crude Terebra variegata salivary gland contents were
extracted with 30% acetonitrile/water in 0.1% trifluoroacetic acid.
An aliquot of the crude venom was analyzed using LC-MS on an
Orbitrap XL mass spectrometer to determine the number of
teretoxins present. LC-MS analysis was repeated after reduction of
the crude venom to determine the number of cysteine residues
present in each component. At this point, Tv1 was selected for
further analysis due to its similarity in molecular weight and
number of cysteines to M superfamily conotoxins. A reduced
version of Tv1 was dissociated using CAD (Fig. 1b, and Figure S1
in File S1) and the dimethyl lysine analogue version of the
teretoxin was dissociated using ETD (Fig. 1b and Figure S2 in File
S1). The ETD MS/MS spectrum resulted in almost 100%
sequence coverage. The sequence assignment by ETD could be
supported with the CAD spectrum on the reduced toxin (Fig. 1b
and Figure S1 in File S1). There were two places of ambiguity in
the Tv1 peptide sequence: (1) the inherent uncertainty of
isoleucine (Ile) and leucine (Leu) at the third position, which
cannot be differentiated with the mass spectrometer used for this
analysis, and (2) the order of the first two amino acids, Thr, Arg or
Arg, Thr. The second ambiguity was resolved based on the
absence of the c1 ion, and the resulting Tv1 sequence was
determined as TR(I/L)CCGCYWNGSKDVCSQSCC. However,
the Ile/Leu ambiguity at position 3 could not be resolved as there
was not sufficient crude extract remaining after MS characteriza-
tion.
Figure 1. Discovery and characterization of disulfide–rich Tv1 teretoxin. An integrated approach for characterizing sample limited disulfide
peptidic natural products was applied: a) RP-HPLC on-line separation of Terebra variegata venom (highlighted is the region where the sequenced
peptide eluted). b) ETD and CAD MS/MS analysis recorded on the native peptide to determine the sequence of Tv1 peptide. c) RP-HPLC of linear and
folded versions of chemically synthesized Tv1 peptide. d) MS/MS spectrum of partially reduced and alkylated Tv1 used to determine the disulfide
connectivity. e) NMR solution structure of folded Tv1 peptide. f) Bioactivity of 20 mM of Tv1 (2) versus normal saline (NS) (2) solution injected into
polychaete worms. Y-axis indicates level of activity, where 3 is the normal activity of the NS injected worm, 1 and 2 indicate decreased activity due to
partial paralysis.
doi:10.1371/journal.pone.0094122.g001
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To confirm Tv1 de novo assignment, the peptide was chemically
synthesized using Fmoc Solid Phase Peptide Synthesis (SPPS). Due
to inherent uncertainty in the amino acid sequence at position 3,
both Ile3 and Leu3 containing peptides were synthesized and
subjected to the same chemical derivatization strategy. The two
synthesized Tv1 teretoxins both resulted in an MS/MS spectrum
identical to the native peptide, confirming the de novo sequence
assignment in which TR is the order of the first two amino acids,
but with remaining I/L uncertainty at position 3 due to the mass
spectrometer used (Fig. 2 and Figure S2 in File S1). The novel
peptide teretoxin, Tv1 from venomous marine snail Terebra
variegata was thus identified and its sequence was determined.
Synthesis, Characterization and Oxidative Folding of Tv1
Tv1 was chemically synthesized using Fmoc Solid Phase Peptide
Synthesis without prior knowledge of disulfide connectivity, and all
cysteine residues were protected with a standard side chain
protecting group, trityl. The synthesized Tv1 peptide was purified
to 99% using RP-HPLC (Figure S3 in File S1) and its mass was
confirmed by MALDI mass spectrometry. The expected average
mass of the linear peptide [M+H] 2316.3 m/z was observed
(Figure S4 in File S1). Tv1 was folded using thiol-assisted air
oxidation reaction and purified by HPLC (Figure S3 in File S1).
The mass of folded Tv1, 2310.7 m/z, is reduced by 6 Da
confirming that three intramolecular disulfide bonds had been
formed (Figure S5 in File S1). No differences were observed in
synthesis and folding kinetics of the two Tv1 peptides with Ile or
Leu at the third amino acid position, and both versions of Tv1
were used to determine the disulfide connectivity of the peptide.
Disulfide Mapping of Tv1
Due to the limited number of enzymatic cleavage sites and the
presence of adjacent cysteine residues, traditional strategies for
disulfide mapping such as tryptic digestion and acid hydrolysis
were difficult to implement. The disulfide connectivity of Tv1 was
independently determined by MS/MS mapping and NMR
spectroscopy. For MS/MS mapping, a partial reduction and dual
alkylation protocol was applied using reducing agent TCEP-HCl
(Tris(2carboxyethyl)phosphine hydrochloride) and alkylating
agents NEM (N-ethylmaleimide) and IAM (iodoacetamide) [28–
30]. Chemically synthesized and oxidatively folded Tv1 peptide
was first partially reduced at pH 3.0 with TCEP, and subsequently
alkylated with NEM. The partially alkylated Tv1-NEM peptide
was reduced further with TCEP at pH 7.0 and alkylated again
with IAM this time. Dual NEM/IAM alkylation resulted in Tv1
peptide species that were labeled with 2, 4 or 6 NEM and IAM
groups (Fig. 3 and Figure S6 in File S1). The location of NEM and
IAM modifications in each of the six partially reduced species was
determined by matching the MS/MS b- and y- series ions to
theoretical patterns. All six partially reduced species provided
complementary, non-contradictory information and the resulting
connectivity was determined to be Cys4–Cys20, Cys5–Cys21 and
Cys7–Cys16 (Fig. 3 and Table S1 in File S1). Tv1 has a cysteine
scaffold similar to M Superfamily conotoxins (Table 1), but it
displays a disulfide pattern previously unknown in native cone
snail peptides [23,31–35] with a disulfide bridge formed between
the two middle cysteines (Cys7 and Cys16) and a parallel 2-
disulfide bond ‘‘staple’’ (Cys4–Cys20 and Cys5–Cys21) linking the
N- and C-termini of the peptide.
Table 1. Comparison of Teretoxin Tv1 and known M superfamily Conotoxins.
Teretoxin Sequence Target(s) Reference
Tv1 TRICCGCYWNGSKDVCSQSCC unknown This work
Conotoxin
MrIIIe VCCPFGGCHELCYCCD* unknown [23,33,49]
TxIIIa CCSWDVCDHPSCTCCG* unknown [50,51]
MrIIIa GCCGSFACRFGCVOCCV unknown [50]
TxIIIb CCPPVACNMGCKPCC * unknown [31,50]
Reg12a GCCOOQWCGODCTSOCC unknown [52]
Tx3f RCCKFPCPDSCRYLCC* unknown [31]
Qc3.1 ACCDPDWCDAGCYDGCC unknown [23]
BuIIIA VTDRCCKGKRECGRWCRDHSRCC* Nav1.2,1.3, 1.4 [53]
BuIIIB VGERCCKNGKRGCGRWCRDHSRCC* Nav1.2,1.3,1.4,1.5,1.7 [53]
BuIIIC IVDRCCNKGNGKRGCSRWCRDHSRCC** Nav1.2,1.3,1.4,1.7 [53]
MIIIA ZGCCNVPNGCSGRWCRDHAQCC* TTX-r [54]
KIIIA CCNCSSKWCRDHSRCC* TTX-r [55]
PIIIA ZRLCCGFOKSCRSRQCKOHRCC* Nav1.4 [38]
GIIIA RDCCTOOKKCKDRQCK-OQRCCA* Nav1.2, 1.4, 1.6–1.8 [56]
GIIIB RDCCTOORKCKDRRCK-OMKCCA* TTX-r [56]
GIIIC RDCCTOOKKCKDRQCK-OLKCCA* TTX-r [56]
CnIIIA GRCCDVPNACSGRWCRDHAQCC* TTX-r [54]
CnIIIB ZGCCGEPNLCFTRWCRNNARCCRQQ TTX-r [54]
SmIIIA ZRCCNGRRGCSSRWCRDHSRCC TTX-r, TTX-s [57]
SIIIA ZNCCNGGCSSKWCRDHARCC* TTX-r, TTX-s [58]
CIIIA GRCCEGPNGCSSRWCKDHARCC* TTX-r [59]
doi:10.1371/journal.pone.0094122.t001
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Characterization of Tv1 by NMR Solution Structure
Derivation
To confirm the disulfide bond connectivity derived from MS,
the solution structure of Tv1 was derived using standard
homonuclear proton NMR techniques on unlabeled folded
synthetic peptide. Initial NMR experiments were carried out on
Tv1 peptide containing either Ile or Leu at the third position. The
spectra were very similar for both versions of the peptide, with the
only differences found in the signals of the Ile3 and Leu3 residues
themselves, indicating that both peptides adopt the same structure.
Subsequent NMR structural calculations were carried out using
only the Ile3 form of the peptide.
Proton assignments were obtained from 2D NOESY and
TOCSY spectra, and carbon chemical shifts were assigned with
the help of a natural-abundance 13C-HSQC spectrum (Table S2
in File S1). Initial structure calculation runs were carried out using
only manually assigned Nuclear Overhauser Effect (NOE) distance
restraints. Disulfide connectivities were then determined based on
proximity of cysteine residues in the 10 lowest-energy structures
and were in agreement with the disulfide bond pattern derived by
MS analysis.
Direct evidence for the Cys7–Cys16 disulfide bond was also
observed from NOE crosspeaks between the HN of Cys16 and the
Ha of Cys7, as well as a number of connectivities to the two
flanking residues, Gly6 and Tyr8 (Figure S7 in File S1). Once the
disulfide linkages were determined, additional distance restraints
for the disulfide bonds were introduced. The final round of
structure calculations was run with covalent bonds between the
connected cysteine side chains. A bundle of the 10 lowest-energy
structures was obtained with an RMSD of 0.42 Å for backbone
and 0.74 Å for all heavy atoms (Figure S8 and Table S3 in File
S1). A query for other peptide structures similar to the determined
Tv1 structure using the software packages VAST [36] or
PDBeFOLD [37] did not yield any hits, indicating that the
structure of Tv1 represents a new fold for small peptide toxins.
The most prominent and best-defined structural feature is a b-
hairpin from Cys7 to Cys16 that is clamped together by the
disulfide bond formed between these two residues (Fig. 1 and
Figure S9 in File S1). The remainder of the peptide wraps around
the side chain aromatic ring of Tyr8, in particular through the
formation of hydrophobic interactions with the side chains of Ile3
and Val15. The N- and C-terminal loops are clamped together in
an antiparallel way through the Cys4–Cys20, Cys5–Cys21 double-
disulfide bond arrangement, giving the whole teretoxin the shape
of a flattened ellipsoid (Figure S8 in File S1). Coordinates for the
Tv1 structures have been submitted to the PDB and are available
under accession code 2mix.
Although Tv1 has a cysteine scaffold similar to M Superfamily
conotoxins (Table 1), the observed differences in fold and disulfide
bonding pattern are not surprising given the lack of sequence
homology to M superfamily conotoxins. It is interesting to note
that the loop between C3 and C4 is at least 4 amino acid residues
longer in Tv1 compared to any of the other listed conotoxins,
which is in agreement with the fact that these are the residues
involved in the formation of the b-hairpin that is lacking in
conotoxins. No b-strand structures are found in any of the other
M-superfamily conotoxins (Fig. 4) [28–32]. To our knowledge, the
only other example of Tv1’s disulfide bond pattern was found in
an active non-native minor refolding product for m-conotoxin
PIIIA [38]. The 3D structures of both the native and non-natively
refolded forms of PIIIA are very different from the structure of
Figure 2. Sequence identification of Tv1 teretoxin. Shown is the native toxin (black) and the synthesized toxin (green) MS/MS spectrum
recorded on a (M +6H)+6 ion after conversion of cysteine residues to dimethyl lysine analogs. Note the overlap of all major fragment ions. The
sequence is given above the spectrum and observed c and z-type fragment ions are indicated in the sequence with z and y, respectively. Doubly
charged fragment ions of type c and z are labeled with +2, triply charged ions are of type c and z are indicated with *, z-type fragment ions that
resulted from cleavage at cysteine with subsequent loss of the cysteine side chain are denoted in italic [60] and charge reduced species are labeled in
the spectrum with #. The spectrum was recorded at a resolution of 7500 at m/z 400 and all fragment ions have a mass accuracy of better than
5 ppm.
doi:10.1371/journal.pone.0094122.g002
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Tv1 as they contain segments of a-helix and no b-sheet structure.
The difference between Tv1 and the PIIIA refolded product with
the same disulfide bridge arrangement further supports the
conclusion that Tv1 is representative of a new and unique group
of peptide toxins.
Figure 3. Disulfide mapping of Tv1. a) RP-HPLC fractionation of all differentially folded peaks (on HPLC gradient of 20% to 35% buffer B (80%
Acetonitrile, 0.1% TFA) in buffer A (water, 0.1% TFA) over 75 min. b) MS-MS spectrum of partially reduced peptide peaks showing representative
alkylated b and y ions. c) Schematic representation of Tv1 with predicted disulfide bridges.
doi:10.1371/journal.pone.0094122.g003
Figure 4. Structural comparison of Tv1 teretoxin and M-superfamily conotoxins. Comparison of the NMR structure of Tv1 with that of M
superfamily conotoxins SmIIIA, mr3e, and KIIIA reveals significant structural differences between Tv1 and these conotoxins despite all having the
same cysteine scaffold CC-C-C-CC. All structures are shown in cartoon representation with disulfide bonds highlighted in yellow. All figures were
prepared using PyMol (www.pymol.org). Conotoxin structural references are as follows: MrIIIe [33] SmIIIA [61] and KIIIA [62].
doi:10.1371/journal.pone.0094122.g004
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Bioactivity Assay
To determine if synthetic Tv1 is biologically active, the peptide
was injected into polychaete worms, which are the natural prey of
terebrid snails. Injections of 20 mM Tv1 (Ile) into N. virens
polychaete worms caused partial paralysis (Fig. 1f, Table 2). This
finding is consistent with the recent study where crude terebrid
venom extract exhibited nAChR inhibitory activity [39]. Inhibi-
tion of nicotinic receptors at the neuromuscular junction can result
in paralysis. Further experiments are underway to determine the
specific molecular target of Tv1.
Conclusion
A novel teretoxin, Tv1, from Terebra variegata was structurally
identified and found to be biologically active. The strategy applied
to the discovery and characterization of Tv1 allows for the
unequivocal analysis of minuscule amounts of sample. Four
nanograms of venom sample was used to elucidate the amino
acid sequence of Tv1. Such a minute amount of sample would
previously be inaccessible for natural product discovery from
venomous organisms. There are over 400 different species of
terebrids, each predicted to express between 50–200 different
peptide toxins in their venom. With an integrated approach of
mass spectrometry, chemical peptide synthesis, and NMR as
applied to Tv1, it will be possible to access the substantial quantity
of disulfide-rich peptides (.80,000) in the Terebridae. The novel
structural features of Tv1 suggest that teretoxins will reveal
different mechanisms of action and different target specificities
compared to disulfide-rich peptide toxins previously characterized
and used as tools in neuroscience and as drug leads. In addition,
an abundance of gastropods, including most species of the
venomous marine conoidean snails, are smaller than 8 mm in
shell size [40], highlighting the need for an efficient microscale
mass spectrometry sequencing strategy. The sample limited
integrated approach presented here can significantly enhance
discovery and characterization of the vast disulfide-rich natural
product peptide libraries produced by various venomous organ-
isms.
Methods
Venom Extraction and De-Novo Sequencing
Four Terebra variegata snails were collected by MH from the Las
Perlas Archipelago in Panama on an expedition with the RV
URRACA and glands were dissected. Scientific research permits
were provided by the Smithsonian Tropical Research Institute
Permit Office (STRI-SPO) and The Panama Aquatic Resources
Authority (ARAP). Pooled crude venom contents from all 4
specimens were extracted with aid of light sonication in 30%
acetonitrile/water acidified with 0.1% trifluoroacetic acid and
centrifuged. The supernatant was lyophilized and stored at 2
20uC. An aliquot of crude venom was pressure loaded onto a self-
packed PicoFrit column (New Objective) with integrated emitter
tip (360 mm o.d., 75 mm i.d., 15 mm tip), packed with 6 cm of
reverse-phase C18 material (Alltima C18 5 mm beads, Alltech
Associates), rinsed for 10 min with 0.1 M acetic acid and
subsequently gradient eluted with a linear gradient from 0 to
100% B in 30 min (A = 0.1 M acetic acid, B = 70% acetonitrile in
0.1 M acetic acid, flow rate 120 nL/min) into an LTQ Orbitrap
XL with ETD (ThermoFisher Scientific), using a home-built micro
electrospray source with a liquid junction.
The instrument was operated in data dependent mode cycling
through full scan (300–2,000 m/z, single scan) followed by 8 MS/
MS scans on the 8 most abundant ions from the immediate
preceding full scan. Next, aliquots of reduced and iodoacetamide
alkylated crude venom were pressure loaded onto a self-packed
PicoFrit column (New Objective) with integrated emitter tip as
described above and eluted using the same gradient as above into
the LTQ Orbitrap XL with ETD. Instrument was operated in a
data dependent mode cycling through a full scan (300–2,000 m/z,
single scan) followed by 8 MS/MS scans on the 4 most abundant
ions from immediate preceding full scan. The instrument was
programmed to acquire first 4 CAD and then 4 ETD spectra on
the 4 most abundant ions. The cations were isolated with a 2-Da
mass window and set on a dynamic exclusion list for 30 seconds
after they were first selected for MS/MS. Target value for MS/
MS was set to 104 cations and 106 anions of fluoranthene. For
CAD an activation time of 30 ms was chosen. For ETD the ion/
ion reaction time was set to 100 ms. In both cases 4 scans were
averaged per MS/MS spectrum. In a majority of cases, complete
sequence elucidation after this initial analysis was not possible, but
based on this initial screen optimal charge states for subsequent
targeted ETD analysis were chosen. For subsequent analysis either
reduced, iodoacteamide alkylated, or dimethyl lysine analog
versions of toxin were pressure loaded onto the self-packed
columns as described above. The column was rinsed for 10 min
(for reduced or iodoacetamide alkylated toxins) or for 20 min (for
lysine dimethyl analog versions of toxins) with 0.1 M acetic acid
and gradient eluted into the LTQ XL as described above. To
obtain higher quality MS/MS spectra in this second analysis, 12
scans were averaged and the data acquired in high resolution with
7,500 resolution setting. The spectra were manually interpreted
(Figures S1 and S2 in File S1).
Synthesis and Purification of Tv1
Tv1 peptide was synthesized by microwave assisted Fmoc SPPS
on a CEM Liberty synthesizer using standard side chain
protection. Standard Fmoc cysteine with side chain protecting
group Trityl (Fmoc-Cys (Trt)-OH) was used for all cysteine
residues in the Tv1 peptide. Following treatment of peptidyl resin
with Reagent K [92.5% TFA (Trifluoroacetic acid), 2.5% TIS
Table 2. Tv1 bioactivity in polychaete worms.
Activity % Time spent
Tv1 (20 mM) NSS
at 0 0.995 1.45
Between 0 and 1 74.47 0
Between 1 and 2 19.98 0
Between 2 and 3 4.55 98.55
doi:10.1371/journal.pone.0094122.t002
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(Triisopropylsilane), 2.5% EDT (1,2 Ethanedithiol) and 2.5%
water, 4 hr)] and cold ether precipitation, crude Tv1 was purified
by RP-HPLC using an X-Bridge semipreparative column (106150
mm, 5 mm particle size, Waters Corporation, Milford, MA, USA).
Elution was carried out at 5 mL/min with 20% buffer B (80%
Acetonitrile, 0.1% TFA) and 80% buffer A (0.1% TFA) for the
first 5 min, then increasing buffer B to 35% in 45 min. HPLC
buffer composition remained the same all through the work. Purity
of collected peptide was confirmed by RP-UHPLC using an
Acquity UPLC (BEH 300 C18 1.7 mm, Waters Corporation)
column and eluted using a linear gradient from 0% to 75% buffer
B in 3.5 min (Figure S3 in File S1). The identity of synthesized
peptide was confirmed by molecular mass measurement of
purified peptide using MALDI-TOF (Waters, Micromass,
CHaCN matrix) (Figure S4 in File S1).
Oxidative Folding of Tv1
A one-step thiol-assisted oxidation was used to prepare folded
Tv1 peptide. The linear peptide (20 mM) was incubated in 0.1 M
Tris –HCl, 0.1 M NaCl, 100 mM EDTA, 1 mM GSH, 1 mM
GSSG, pH 7.5. The folding reaction was terminated by acidifi-
cation with 8% formic acid at 15 min, 30 min, 1, 2, 3, 4, and 24 h
and the folding yield monitored using UHPLC. A preparative
scale folding reaction was then conducted at an optimized time of
2 h, and the folded peptide was purified using X-Bridge
semipreparative column (as mentioned earlier). Elution was
carried out at 5 mL/min with 15% buffer B and 85% buffer A
for the first 5 min, then increasing buffer B to 35% in 45 min. The
purity was confirmed using Acquity UHPLC column (Figure S3 in
File S1), and the molecular mass of the oxidized peptide was
confirmed by MALDI-TOF (Figure S5 in File S1).
Disulfide Mapping by Tandem MS/MS
A partial reduction and dual alkylation strategy was employed
using reducing agent TCEP (Tris carboxy ethyl-phosphine
hydrochloride, Thermo-Fisher) and alkylating agents NEM (N-
ethylmaleimide, Sigma) and IAM (iodoacetamide, Sigma). Con-
ditions for the partial reduction and alkylation of folded peptides
were optimized modifying previous protocols [30,41]. Briefly, 9 ml
of folded peptide (1 mM) was dissolved in 0.1 M citrate buffer,
pH 3.0 and 1 ml of TCEP (20 mM in 0.1 M citrate buffer, pH 3.0)
was added to it. Reduction was carried out at 4uC for 90 min and
was terminated by injecting onto an RP-HPLC column [X-Bridge
analytical column (56150 mm, 5 mm particle size, Waters
Corporation, Milford, MA, USA)] and eluted with 20% buffer B
in buffer A for 5 min, then increasing buffer B to 35% in 75 min.
Six partially reduced peaks (Figure S6 in File S1) were each
collected directly into microcentrifuge tubes containing 100 ml
NEM (200 mM in 0.1 M citrate buffer pH 3) and incubated at
37uC for 2 h in the dark. Partially reduced and alkylated reactions
were then lyophilized and desalted to remove unreacted NEM
using UHPLC. The desalted fractions were incubated with
100 mM TCEP at 55uC for 1 h to completely reduce the NEM
labeled peptide and alkylated with 275 mM IAM for 2 h at 37uC
in dark. The alkylation steps resulted in peptide species that were
labeled with 2, 4 or 6 NEM or IAM groups. The labeled
lyophilized species were suspended in 0.5% formic acid and
subjected to LC-MS/MS analysis on 43 mm HPLC-Chip/Q-
TOF using a 7 min gradient to resolve fully labeled species from
those with incomplete alkylations. Data was collected in targeted
and auto MS/MS mode and processed using molecular feature
extraction (MFE) software to detect unique peptide features (MS
and MS/MS spectra) followed by sequence matching on
MassHunter Bioconfirm Qual B.05 software (Table S1 in File S1).
NMR Solution Structure Derivation
Samples for Nuclear Magnetic Resonance (NMR) studies were
prepared by dissolving lyophilized oxidized peptide into either a
9:1 ratio of H2O:D2O or in 100% D2O at a concentration of
,260 mM. Sample pH was adjusted to pH 6.0 and 50 mM
trimethylsilyl propanoic acid was added as a reference compound.
Spectral acquisition was carried out at 5uC on a Varian Inova
600 MHz NMR spectrometer equipped with a cryogenically
cooled HCN probe. 2D-TOCSY spectra were acquired in 90%
H2O (64 scans with 10246512 points) and D2O (48 scans with
10246512 points) with spin-lock times of 60 ms, whereas 2D-
NOESY spectra were acquired with mixing times of 200 ms in
H2O with a matrix size of 10246512 points in 64 scans and in
D2O with a similar matrix size in 112 scans. A natural abundance
1H13C HSQC correlation spectrum was also acquired in 1024
scans with a matrix size of 1024680 points. Acquired spectra were
processed with NMRPipe [42] and analyzed with CCPNmr
Analysis [43]. Proton assignments were made by comparison of
TOCSY and NOESY spectra, and used to assign the 13C chemical
shifts through the HSQC spectrum (Table S2 in File S1). Distance
restraints for structural calculations were obtained from 2 NOESY
spectra: one spectrum collected in 90% H2O with a mixing time of
200 ms and another spectrum collected in D2O with a mixing
time of 400 ms. Manual assignment was performed for about 90%
of all NOE cross-peaks. Dihedral angle restraints were derived
from the assigned chemical shifts using the software TALOS+
[44]. Structural calculations were carried out with ARIA2 [45]/
CNS [46]. Initial structural calculations were conducted using only
the manual NOE assignments (with distances automatically
calibrated by the software based on peak volumes) and without
any restraints for the disulfide bonds. An ARIA2 run consisting of
8 iterations of simulated annealing followed by explicit water
refinement of the 10 lowest-energy structures was performed.
Disulfide connectivities were determined based on this initial
structural bundle and included in the final round of structural
calculations as covalent bonds. Eight iterations were performed in
ARIA with 20 structures generated per iteration and the 7 lowest
energy structures of each iteration forming the structural ensemble
for the next iteration. For this run, NOE assignments were allowed
to be automatically adjusted by the software during the
calculation. For the last iteration, 100 structures were generated,
and ten lowest-energy solutions were subjected to explicit solvent
refinement. The quality of the final structural bundle was assessed
by Procheck NMR (Table S3 in File S1) [47].
Bioactivity Assay on Polychaete Worms
Nereis virens (polychaete worms) (,3.5 g) were maintained at 4uC
in salt water prior to injection. Worms were laid on a Styrofoam
block and injected with an insulin syringe. A modified needle cap
was used to maintain a consistent 1.5 mm depth of needle
puncture. Worms were injected between the 5th and 7th segments
on the ventral anterior end with the aim of targeting the ventral
nerve cord. Control worms were injected with 12 ml of 0.9%
normal saline solution (NSS). Lyopholized samples of Tv1 toxin
were resuspended in NSS and diluted to a concentration of 20 mM
which was confirmed using a ThermoScientific Nanodrop 2000c
spectrophotometer. At least three worms were used for each trial-
one saline control and two injected with Tv1 toxin for a total of 3
trials. After injection, the worms were transferred to side-by-side
containers filled with room temperature salt water. The worm
movements were then recorded by video in order to evaluate the
effects of the toxin over a period of at least 3.5 hours. Varying
temperature elicits different phenotypic responses from N. virens:
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water at 4uC has an anesthetizing effect, while room temperature
prompts a vigorous response [48].
Taking the worms from 4uC water and immersing them in
room temperature water (25uC) immediately after injection
stimulates an active response from the worms, making it easier
to recognize paralytic (or partially paralytic) effects induced by a
novel toxin in the first minutes after injection. Worms were
observed every other day for two weeks after injection. The
recorded videos were analyzed blind by two independent
observers; the activity of each worm over a small time interval
was noted on a scale of 1–3, with 3 being extremely active and 1
being inactive. Each video was analyzed and annotated three times
by each observer. Observations for each worm began at the time
of injection (Table S4 in File S1). The numerical results of the two
independent viewings were averaged together if results were
similar, if two viewers disagreed, a third observer was employed to
review the disputed section of video. Results of relative activity vs.
time were plotted to quantify the phenotypic effects of the toxin
and saline injection on N. virens (Fig. 1f). The data was also used to
calculate what percentage of time each worm spent inactive (a
rating of 1), active (an averaged rating of 1.5–2), and extremely
active (rating 2.5–3) (Table 2).
Supporting Information
File S1 This file contains Figure S1–Figure S9 and Table
S1–Table S4. Figure S1, CAD of native Tv1. MS/MS spectrum
recorded on a (M +2H)+2 ion after reduction of cysteine residues.
The sequence is given above the spectrum and observed b, a and
y-type fragment ions are labeled in the spectrum. Observed
peptide backbone cleavage is indicated in the sequence above with
z and y for N- and C-terminal fragment ions, respectively. Doubly
charged fragment ions are labeled with +2. The neutral loss of
water from the precursor ion is shown as [M+2H]+2–H20, but
neutral losses of fragment ions are not labeled. The spectrum was
recorded at a resolution of 7500 at m/z 400 and all fragment ions
have a mass accuracy of better than 5 ppm. Figure S2, ETD of
native (black) and synthetic Tv1 (blue). MS/MS spectrum
recorded on a (M +6H)+6 ion after conversion of cysteine residues
to dimethyl lysine analogs. The sequence is given above the
spectrum and observed c and z-type fragment ions are indicated in
the sequence with z and y, respectively. Doubly charged fragment
ions of type c and z? are labeled with +2, triply charged ions are of
type c and z are indicated with *, z-type fragment ions that
resulted from cleavage at cysteine with subsequent loss of the
cysteine side chain are denoted in italic and charge reduced species
are labeled in the spectrum with #. The spectrum was recorded at
a resolution of 7500 at m/z 400 and all fragment ions have a mass
accuracy of better than 5 ppm. Figure S3, RP-UHPLC chro-
matograms of Tv1 linear and oxidized peptide at 214nm. During a
pilot folding reaction, over 90% of the linear Tv1 peptide fully
oxidized and showed a peak at 1.58 minute in comparison to 1.83
minute linear Tv1 peak at the gradient of 0–75% buffer B (80%
acetonitrile, 0.1% TFA) in buffer A (0.1% TFA) within two hours.
Figure S4, Analysis of linear Tv1 peptide by MALDI-TOF mass
spectrometry. MALDI-TOF spectrum of Tv1 peptide using a-
Cyano-4-hydroxycinnamic acid matrix. Figure S5, Analysis of
oxidized Tv1 peptide by MALDI-TOF mass spectrometry.
MALDI-TOF spectrum of Tv1 peptide using a-Cyano-4-hydro-
xycinnamic acid matrix. Figure S6, RP-UHPLC analysis of partially
reduced Tv1 peptide. On a UPLC (BEH 300 C18 1.7 mm, Waters
Corporation, Milford, MA, USA) column, a linear gradient of 0–
75% buffer B (80% acetonitrile, 0.1% TFA) in buffer A (0.1%
TFA) over 6 minutes and peaks were assigned by their degree of
reduction. Labels indicate how many disulfides are present. Figure
S7, NOE contacts confirming the C7–C16 disulfide bond. An
overlay of the HNHa fingerprint region of the NOESY (in black)
and TOCSY (in blue) spectra shows NOE crosspeaks linking Cys
16 and Cys 7 as well as contacts in the residues flanking the C7–
C16 disulfide bond (C7-S17, Y8-C16, G6-C16, G6-N18). Figure
S8, Bundle of the 10 lowest energy structures of Tv1 after explicit
water refinement. The 10 lowest energy structures are shown in
stick representation, displaying the tight convergence found in the
final structural bundle. Figure S9, Structure of Tv1. An overlay of
a cartoon representation and a stick model of the lowest-energy
structure of Tv1 shows the b-sheet character of the peptide and
reveals the important role of the Tyr 8 side chain in the formation
of a small hydrophobic core. Table S1, Predicted and observed of
b and y ions of differentially alkylated peptides by auto and
targeted MS/MS analysis. Table S2, Chemical shift assignments
of Tv1 (in ppm). Table S3, Structural statistics for the final 10
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46. Brünger AT, Adams PD, Clore GM, DeLano WL, Gros P, et al. (1998)
Crystallography & NMR System: A New Software Suite for Macromolecular
Structure Determination. Acta Crystallogr D Biol Crystallogr D54: 905–921.
47. Laskowski RA, Rullmann JAC, MacArthur MW, Kaptein R, Thornton JM
(1996) AQUA and PROCHECK-NMR: Programs for checking the quality of
protein structures solved by NMR. J Biomol NMR 8: 477–486.
48. Imperial JS, Chen P, Sporning A, Terlau H, Daly NL, et al. (2008) Tyrosine-rich
conopeptides affect voltage-gated K+ channels. J Biol Chem 283: 23026–23032.
49. Wang Q, Jiang H, Han Y-H, Yuan D-D, Chi C-W (2008) Two different groups
of signal sequence in M-superfamily conotoxins. Toxicon 51: 813–822.
50. Kaas Q, Westermann J-C, Halai R, Wang CKL, Craik DJ (2008) ConoServer, a
database for conopeptide sequences and structures. Bioinformatics 24: 445–446.
51. McDougal OM, Turner MW, Ormond AJ, Poulter CD (2008) Three-
dimensional structure of conotoxin tx3a: An m-1 branch peptide of the M-
superfamily. Biochemistry 47: 2826–2832.
52. Franco A, Pisarewicz K, Moller C, Mora D, Fields GB, et al. (2006)
Hyperhydroxylation: anew strategy for neuronal targeting by venomous marine
molluscs. In Muller E.G. Werner, editor. Progress in Molecular and Subcellular
Biology. Springer. pp. 83–99.
53. Holford M, Zhang M-M, Gowd KH, Azam L, Green BR, et al. (2009) Pruning
nature: Biodiversity-derived discovery of novel sodium channel blocking
conotoxins from Conus bullatus. Toxicon 53: 90–98.
54. Zhang M-M, Fiedler B, Green BR, Catlin P, Watkins M, et al. (2006) Structural
and functional diversities among mu-conotoxins targeting TTX-resistant sodium
channels. Biochemistry 45: 3723–3732.
55. Zhang M-M, Green BR, Catlin P, Fiedler B, Azam L, et al. (2007) Structure/
function characterization of micro-conotoxin KIIIA, an analgesic, nearly
irreversible blocker of mammalian neuronal sodium channels. J Biol Chem
282: 30699–30706.
56. Adams DJ, Alewood PF, Craik DJ, Drinkwater RD, Lewis RJ (1999) Conotoxins
and their potential pharmaceutical applications. Drug Dev Res 46: 219–234.
57. West PJ, Bulaj G, Garrett JE, Olivera BM, Yoshikami D (2002) Mu-conotoxin
SmIIIA, a potent inhibitor of tetrodotoxin-resistant sodium channels in
amphibian sympathetic and sensory neurons. Biochemistry 41: 15388–15393.
58. Yao S, Zhang M-M, Yoshikami D, Azam L, Olivera BM, et al. (2008) Structure,
dynamics, and selectivity of the sodium channel blocker mu-conotoxin SIIIA.
Biochemistry 47: 10940–10949.
59. Shon KJ, Olivera BM, Watkins M, Jacobsen RB, Gray WR, et al. (1998) mu-
Conotoxin PIIIA, a new peptide for discriminating among tetrodotoxin-sensitive
Na channel subtypes. J Neurosci 18: 4473–4481.
60. Chalkley RJ, Brinkworth CS, Burlingame AL (2006) Side-chain fragmentation of
alkylated cysteine residues in electron capture dissociation mass spectrometry.
J Am Soc Mass Spectrom 17: 1271–1274.
61. Keizer DW, West PJ, Lee EF, Yoshikami D, Olivera BM, et al. (2003) Structural
basis for tetrodotoxin-resistant sodium channel binding by mu-conotoxin
SmIIIA. J Biol Chem 278: 46805–46813.
62. Khoo KK, Gupta K, Green BR, Zhang M-M, Watkins M, et al. (2012) Distinct
disulfide isomers of m-conotoxins KIIIA and KIIIB block voltage-gated sodium
channels. Biochemistry 51: 9826–9835.
Sample Limited Venom Peptide Characterization
PLOS ONE | www.plosone.org 9 April 2014 | Volume 9 | Issue 4 | e94122
